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arteriolar remodeling; large conductance calcium-activated potassium channel; myogenic tone OBESITY IS AN INDEPENDENT risk factor for cardiovascular disease, atherosclerosis, dyslipidemia, and stroke (58) , with increased peripheral vascular resistance being a common and consistent feature (31, 50). Increased vascular resistance in obesity may result, in part, from decreased function of the large conductance Ca 2ϩ -activated potassium channel (BK Ca ) in vascular smooth muscle. This channel plays a central role in the regulation of vascular tone, both as a regulator of vasoconstriction and a target of vasodilator agents (35, 43) . BK Ca have a high conductance of ϳ240 pS (35), and hence a relatively low level of BK Ca activity can exert a profound hyperpolarizing effect on muscle cell membrane potential, and thus excitability, reducing Ca 2ϩ entry through voltage-sensitive mechanisms and causing relaxation. BK Ca are composed of four pore-forming ␣-subunits and four regulatory ␤-subunits (64, 65) . The ␤ 1 -subunit is highly expressed in various smooth muscle cells, including in arteries (37), and acts to increase the Ca 2ϩ -and voltage sensitivity of the channel (65) . BK Ca are also activated by vasodilator agents including epoxyeicosatrienoic acids (EETs) derived from the action of cytochrome P-450 on arachidonic acid (8) , nitric oxide (NO), and prostacyclin via cGMP and cAMP, respectively (57) . BK Ca may also be stimulated by vasoconstrictor stimuli, through the generation of local Ca 2ϩ -sparks involving activation of ryanodine receptors located on the sarcoplasmic reticulum (36, 40, 52). BK Ca can also modulate responses to contractile stimuli without the generation of Ca 2ϩ sparks (69) . Some studies have examined vascular BK Ca function in various metabolic disease models. Impaired BK Ca function in arteriolar smooth muscle was present in models of insulin resistance (14) , diabetes (15, 47) , and genetic models of obesity (23) and hypertension (3) . However, few studies have examined BK Ca function in a diet-induced obesity model that reflects the etiology of primary human diet-related obesity. Furthermore, the mechanism by which BK Ca function was inhibited in these studies is unclear, with reactive oxygen species (6, 20, 23) or altered BK Ca subunit expression (4, 44, 45) suggested to underlie changes in vascular function. Some recent studies have suggested metabolic disease may selectively reduce vascular BK Ca ␤ 1 -subunit function, reducing the channel sensitivity to changes in membrane potential or intracellular [Ca 2ϩ ]. Cerebral artery BK Ca from ␤ 1 -subunit knockout mice have reduced Ca 2ϩ sensitivity, with the animals having elevated mean arterial blood pressure (BP) and elevated pressure-induced cerebral myogenic tone (5) . In models of diabetes and hypertension, reduced BK Ca Ca 2ϩ sensitivity in cerebral arteries was associated with decreased ␤ 1 -subunit expression (2, 3, 15) and increased myogenic tone in retinal arteries (47).
The hypothesis of the current study was that diet-induced obesity alters BK Ca function and regulation of myogenic tone in rat resistance arteries through altered expression of the BK Ca ␤ 1 -subunit. The study examined the effect of diet-induced obesity on vascular BK Ca expression, function, and myogenic tone in two distinct vascular beds, cremaster (skeletal) muscle arterioles and middle-cerebral arteries. Pressure-induced myogenic constriction is an important component of overall arteriolar tone from both the skeletal muscle and cerebral circulations, and BK Ca are a key regulator of myogenic tone in these vessels (41, 52). The present study utilized a well-characterized high fat, cafeteria-style dietary model of obesity. Animals subject to this diet for 16 wk display significant weight gain as well as mild systolic hypertension, hyperinsulinemia, and hyperleptinemia (29, 67).
MATERIALS AND METHODS

Animals, Diet, and Sample Collection
Male Sprague-Dawley rats (starting age 6 to 7 wk; 212 Ϯ 1 g; n ϭ 137) were fed either standard rat chow (Gordon's Specialty Stockfeeds) or a highly palatable cafeteria-style high-fat diet (HFD) and tap water ad libitum for 16 -20 wk, as described previously (29). Protocols were approved by the University of New South Wales Animal Care and Ethics Committee.
The HFD consisted of foods such as pies, cakes, and biscuits in addition to standard chow. Body weight was measured weekly, and 24-h food intake (in kJ) was measured every 2 to 3 wk. At the end of the diet period rats were anesthetized with sodium thiopentone (100 mg/kg ip; Abbott). Blood samples were taken by cardiac puncture, and blood glucose was measured immediately (Accu-Chek Advantage; Roche Diagnostics Australia). Plasma samples were stored at Ϫ20°C for subsequent measurement of plasma insulin and leptin (Linco Research). Left retroperitoneal and testicular fat were removed and weighed.
Measurement of BP and Heart Rate
BP and heart rate was measured noninvasively with a tail-cuff volume pressure recording system (CODA 6; Kent Scientific Corporation) and CODA data acquisition software (V2; Kent Scientific). During week 1 of the diet period both control and HFD-fed rats (n ϭ 12 of each) were allowed to acclimatize to the holders and tail-cuffs in three training sessions. Measurements were taken at weeks 1 and 16 of the diet period. For each animal 10 -15 measurements were taken in a session. The CODA data acquisition software allowed continuous observation of volume pressure recordings in real-time. Measurements were only excluded if movement of the rat altered the waveform. For each rat 3-10 measurements were averaged for each session.
Real-Time PCR
Pooled samples of first-order cremaster muscle arterioles or the main branches of middle-cerebral arteries were dissected and stored in liquid nitrogen from between 2 and 5 animals/n (n ϭ 6 to 7 of each). The vessels were ground in liquid nitrogen using a mortar and pestle, and RNA was extracted using an RNeasy Mini kit (Qiagen). RNA was quantified using a spectrophotometer (Bio-Rad). Equal amounts of RNA samples were reverse-transcribed into cDNA using a QuantiTect reverse transcription kit (Qiagen). Quantitative RT-PCR was performed using a Mastercycler epgradientS realplex 2 (Eppendorf). Primers were designed to amplify the BK Ca ␣-subunit [forward primer 5=-CTCGAAGTGAAGCTGCCATGA, reverse primer 5=-ACTC-CCGCTTGAGGTACTCGA; (47)], BK Ca ␤1-subunit [forward primer 5=-ACCAATCTCTTCTGCACAGCAGC, reverse primer 5=-AGA-GCTGTGACTGGCAGTTCCTT; (47)], and 18S rRNA [forward primer 5=-CCAGTAGCATATGCTTGTCTCAA, reverse primer 5=-CGACCAAAGGAACCATAACTGATT; (27) ; Sigma-Aldrich]. The reaction mixture contained 10 l of 2ϫ SYBR Green PCR Master Mix (Applied Biosystems), 4 l of cDNA, 2 l each of the relevant forward and reverse primers (final concentration, 500 nmol/l), and RNAse-free water added for a total volume of 20 l. All reactions were performed in triplicate as follows: 10 min at 95°C followed by 40 cycles of 95°C for 15 s and 61°C for 1 min. Melting curves were performed for analysis of PCR product purity. Relative quantification analysis was performed using Realplex 2.0 software (Eppendorf).
Western Blotting
Pooled segments of first-order cremaster muscle arterioles or the main branches of middle-cerebral arteries from between 3 and 9 animals/n (n ϭ 3 to 4 of each) were dissected and stored in liquid nitrogen. The vessels were ground in liquid nitrogen using a mortar and pestle, resuspended in PBS (pH 7.4) containing complete protease inhibitor cocktail (Roche), and centrifuged (3,000 g, 4°C, 5 min). The supernatant was removed and placed on ice and the pellet was snap frozen in liquid nitrogen and processed again as described above. After the second spin the supernatants were pooled and centrifuged (25, 000 g, 4°C, 1 h) . The membrane-enriched pellet was carefully resuspended in PBS containing 0.1% Triton X-100 and protease inhibitor cocktail, aliquoted, snap frozen in liquid nitrogen, and stored at Ϫ80°C. Protein concentration of the samples was determined using the Bradford protein assay (Bio-Rad).
Aliquots of protein extracts (5 g protein) were dissolved in lithium dodecyl sulfate (LDS) sample buffer of 0.5% LDS, 62.5 mmol/l Tris·HCl, 2.5% glycerol, 0.125 mmol/l EDTA (pH 8.5) for 10 min at 70°C. The samples were separated by electrophoresis in bis-Tris polyacrylamide gels using MES SDS running buffer and electroblotted onto polyvinylidene difluoride membranes overnight at 4°C (Invitrogen). After transfer, blots were thoroughly washed, blocked, probed with primary antibody to BK Ca ␣-subunit (KCNMA1, 1:500; APC-107, Alomone, Israel); BKCa ␤1-subunit (KCNMB1, 1:2,000; to amino acids 118 -132, which was a generous gift from Maria Garcia, Merck Pharmaceutical, New Jersey) and specific binding was visualized using alkaline phosphatase-conjugated secondary antibody [Rabbit IgG (Fc portion), Invitrogen; WB7106] and chemiluminescence, according to the manufacturer's instructions (Invitrogen). The blots were stripped and reprobed with actin antibody (1:1,000; Sigma A2066). The intensity of the band corresponding to each full-length protein was quantified by digital densitometry using ImageJ software (National Institutes of Health, Bethesda, MD). Relative intensity for each full-length band was determined by comparison with the intensity of actin staining.
To determine specificity, each antibody was incubated with its cognate peptide to block specific binding. Before use, peptide was added to antibody in a 1-to-1 ratio (wt/wt), mixed, and incubated at 37°C for 1 h, then overnight at 4°C. The blocked antibody was then used in Western blotting detection as described above. Antibody specificity was demonstrated previously (69) .
Immunohistochemistry
Short segments of first-order arterioles from the cremaster muscle and the main branches of middle-cerebral arteries were dissected and pinned to a dish containing Sylgard (Dow Corning). Vessels were fixed in cold acetone for 10 min and washed with PBS. Vessels stained for BK Ca ␣-subunit were preincubated for 2 h in a primary blocking buffer containing 1% BSA (Bovogen Biologicals) and 0.1% Triton X-100 in PBS. For BK Ca ␤1-subunit staining the primary blocking buffer also contained 1% heat inactivated goat serum (1 h, 56°C). Vessels were incubated overnight at 4°C in antibodies against ␣-subunit (Alomone, APC107; 1:500) and ␤ 1-subunit (Merck anti-␤1 to amino acids 118 -132; 1:5,000), both diluted in primary blocking buffer. After washing in PBS (3 ϫ 5 min) vessels were incubated in Alexa 633 goat-anti-rabbit (Invitrogen; 1:100) diluted in a secondary blocking buffer (0.01% Triton X-100 in PBS) for 2 h at room temperature in the dark. After vessels were washed in PBS (3 ϫ 5 min), vessels were mounted using anti-fade mounting medium (DakoCytomation) and imaged in a confocal microscope (Olympus FV1000), using appropriate filters and uniform settings. Single section scans (0.1-0.2 m) were made to construct the confocal stacks shown.
Isolated cremaster muscle arteriole and middle-cerebral artery preparation. Cremaster muscles were dissected and transferred to a chilled (4°C) dissecting dish containing buffer (in mmol/l) of 3 MOPS, 145 NaCl, 5 KCl, 2.5 CaCl2, 1 MgSO4, 1 NaH2PO4, 0.02 EDTA, 2 pyruvate, 5 glucose, and 1% BSA. The brain was dissected and transferred to a dissecting dish containing modified Krebs buffer (in mmol/l) of 111 NaCl, 25.7 NaHCO 3, 4.9 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 11.5 glucose, and 10 HEPES. A segment of the first-order cremaster muscle arteriole or the main branch of the middle-cerebral artery was isolated and transferred to a tissue bath. The tissue bath contained modified Krebs buffer solution bubbled with 5% CO 2-95% N2. This gas mixture is used as resistance vessels are routinely exposed to and function at O2 tensions substantially lower than large arteries (16, 33) . The isolated vessel was cannulated onto glass micropipettes and secured with 10-0 sutures (Alcon Laboratories).
Vessels were checked for leaks at 120 mmHg and stretched to optimum length at this pressure. Vessels were then superfused with warmed Krebs solution (3 ml/min; 34°C for cremaster muscle arterioles, 36°C for middle-cerebral arteries) and initially pressurized to 40 mmHg. The vessel was allowed to develop spontaneous tone and was then equilibrated at 70 mmHg for cremaster muscle arterioles or 80 mmHg for middle-cerebral arteries. Unless otherwise stated, all measurements for cremaster muscle arterioles were made at 70 mmHg and for middle-cerebral arteries at 80 mmHg. Intraluminal diameter was measured using video microscopy and calibrated video calipers. Pressure was measured with a pressure transducer (Abbott Critical Care Systems). Data were recorded with a Powerlab (model 4/25) and Chart v5.5.1 software (ADInstruments).
Experimental Protocols
Responses to BK Ca agonists. In isolated, pressurized (70 mmHg) cremaster muscle arterioles or middle-cerebral arteries (80 mmHg) cumulative concentration-response curves to the BKCa agonists 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS1619; 1-100 mol/l), pimaric acid (PiMA; 0.1-30 mol/l; Alomone Labs, Israel), and tamoxifen (0.01-100 mol/l) were performed alone and in the presence of the BK Ca inhibitor iberiotoxin (IBTX; 0.1 mol/l).
Myogenic tone. After development of spontaneous tone in cremaster muscle arterioles or middle-cerebral arteries (at 70 or 80 mmHg, respectively) the pressure-diameter relationship was measured over the pressure range of 30 -120 mmHg in the absence and presence of IBTX (0.1 mol/l). Pressure changes were randomized, and the vessels were allowed to equilibrate for 5 min at each pressure. At the conclusion of all experiments the passive pressure-diameter relationship was measured in a nominally Ca 2ϩ -free Krebs solution (no added CaCl2 and 2 mmol/l EGTA).
Electron Microscopy
Tissue preparation for electron microscopy was as described previously (60) . In brief, first-order cremaster muscle arterioles from control and obese rats (n ϭ 10, each from a different animal) were dissected from perfusion fixed rats [1% paraformaldehyde, 3% glutaraldehyde in 0.1 mmol/l sodium cacodylate buffer, with 10 mmol/l betaine (pH 7.4)], embedded, sectioned, and imaged at ϫ10 -40 k on a Phillips 7100 transmission electron microscope at 16 megapixel (MP) resolution (camera from Scientific Instruments and Applications, Duluth). Quantitative measurements of wall properties were made from vessel cross sections cut 90°perpendicular to the longitudinal vessel axis from ultrastructural montages taken at ϫ1.5-2.5 k at 16 MP resolution. CellR software (Olympus) was used for gross quantitative measurements.
Statistical Analysis
Results are expressed as means Ϯ SE. Diameter is expressed as a percentage of the passive diameter observed in nominally Ca 2ϩ -free Krebs solution. EC50 was calculated by nonlinear regression of individual concentration-response curves (GraphPad Prism v5). Data were analyzed using a two-way ANOVA followed by t-test for individual groups of data or t-test alone where warranted (GraphPad Prism v5).
Drugs and Chemicals
All chemicals were from Sigma-Aldrich (St. Louis, MO), except where stated. NS1619 and PiMA were dissolved in DMSO and ethanol, respectively, to make a 10 mmol/l stock solution and stored at Ϫ20°C. Vehicle solutions had no effect on vessel responses. IBTX was dissolved in distilled water to make a 10 mol/l stock solution and stored at Ϫ20°C. Tamoxifen 10 mmol/l stock solutions were prepared fresh daily in ethanol. Both PiMA and tamoxifen 1 mmol/l stock solutions contained 37% ethanol to prevent precipitation. All stock solutions were diluted in Krebs buffer to achieve the final concentration.
RESULTS
Effect of HFD
During the diet period the daily energy intake of animals maintained on the HFD was significantly increased compared with control (P Ͻ 0.05; Table 1 ). The HFD consisted of 32.1 Ϯ 1.0% energy from fat, and the control diet consisted of 13.7% (no SE since only 1 food source). At the end of the diet period the obese animals on the HFD had increased body weight and fat mass (P Ͻ 0.05). Nonfasting blood glucose, plasma insulin, and leptin were also increased (P Ͻ 0.05).
Effect of HFD on BP and Heart Rate
During the first week of the diet period there was no difference between systolic/diastolic BP or heart rate between control (121 Ϯ 6/90 Ϯ 5 mmHg, 408 Ϯ 8 beats/min) and HFD-fed rats (127 Ϯ 5/92 Ϯ 5 mmHg, 411 Ϯ 6 beats/min, P Ͼ 0.05; unpaired t-test, n ϭ 11 to 12 of each). At the end of week 16 systolic BP, but not diastolic BP or heart rate, was significantly elevated in HFD-fed (obese, 158 Ϯ 4/110 Ϯ 3 mmHg, 425 Ϯ 15 beats/min) rats compared with control (144 Ϯ 2/100 Ϯ 3 mmHg, 433 Ϯ 11 beats/min, P Ͻ 0.05; two-way ANOVA, n ϭ 11 to 12 of each). 
Effect of Diet-induced Obesity on Cremaster Muscle Arteriole and Middle-cerebral Artery Diameter
At 70 mmHg, the diameter of cremaster muscle arterioles from obese rats was not significantly different from control (80.4 Ϯ 2.5 m vs. 81.3 Ϯ 1.9 m, respectively, P Ͼ 0.05; unpaired t-test, n ϭ 41-43 of each). The passive (maximum) diameter of cremaster muscle arterioles from obese rats was significantly increased compared with control (177.5 Ϯ 3.1 m vs. 168.3 Ϯ 2.4 m, respectively, P Ͻ 0.05; unpaired t-test). Myogenic tone expressed as a percentage of passive diameter was not significantly different between the two groups, 45.5 Ϯ 1.3% in obese and 48.3 Ϯ 1.0% in control (P Ͼ 0.05; unpaired t-test).
In middle-cerebral arteries maintained at 80 mmHg, the diameter of arteries from obese rats was not significantly different from control (175.6 Ϯ 6.1 m vs. 174.0 Ϯ 6.2 m, respectively, P Ͼ 0.05; unpaired t-test, n ϭ 26 of each). Passive (maximum) diameter of middle-cerebral arteries from obese rats was similar to control (288.3 Ϯ 5.8 m vs. 283.7 Ϯ 6.7 m respectively, P Ͼ 0.05; unpaired t-test). Myogenic tone expressed as a percentage of passive diameter was not significantly different between the two groups, 61.2 Ϯ 2.1% in obese and 61.7 Ϯ 2.0% in control (P Ͼ 0.05; unpaired t-test).
Effect of Diet-induced Obesity on mRNA Expression of BK Ca ␣-and ␤ 1 -subunits in Cremaster Muscle Arterioles and Middle-cerebral Arteries
Real time-PCR showed that mRNA expression of BK Ca ␣- (Fig. 1, A and D, respectively) or ␤ 1 -subunits (Fig. 1, B and E, respectively) relative to 18S rRNA, in both cremaster muscle arterioles (Fig. 1, A-C) and middle-cerebral arteries (Fig. 1,  D-F ) from obese rats, was not significantly different from control. There was also no difference in the ratio of ␤ 1 -to ␣-subunit in either vessel from control or obese rats (Fig. 1, C  and F) . Melt curves demonstrated the presence of a single consistent product for each of the subunits. For details, see Supplemental Fig. S1 .
Effect of Diet-induced Obesity on Protein Expression of BK Ca ␣-and ␤ 1 -subunits in Cremaster Muscle Arterioles and Middle-cerebral Arteries
Western blotting of cremaster muscle arteriole and middlecerebral artery proteins showed that BK Ca ␣-subunit expression was similar in obese and control rats (relative to actin; Fig. 2, A  and D and F and I, respectively) . In obese rats there was a significant reduction in ␤ 1 -subunit expression in cremaster muscle arterioles (P Ͻ 0.05; Fig. 2, B and E) . In middlecerebral arteries from obese rats, however, expression of ␤ 1 was increased (P Ͻ 0.05; Fig. 2, G and J) . Furthermore, the ratio of ␤ 1 -to ␣-subunit expression was decreased in cremaster muscle arteriole and increased in middle-cerebral arteries from obese rats (P Ͻ 0.05; Fig. 2, C and H, respectively) . In control rats, the ratio of D) and ␤1-subunit (B and E) relative to 18S rRNA, and the ratio of ␤1-to ␣-subunits (C and F), in cremaster muscle arterioles (A-C) and middle-cerebral arteries (D-F) from control (n ϭ 6) and obese (n ϭ 7) rats. Columns represent means Ϯ SE. P Ͼ 0.05 for each.
BK Ca ␣-and ␤ 1 -subunit Detection by Immunohistochemistry in Cremaster Muscle Arterioles and Middle-cerebral Arteries
BK Ca ␣-and ␤ 1 -subunits were detected exclusively in the smooth muscle of cremaster muscle arterioles (Fig. 3, A-F) and middle-cerebral arteries (Fig. 3, G-L) , being absent from the endothelium. In cremaster muscle and middlecerebral vessels from control and obese animals, the ␣-and ␤ 1 -subunits were present on the cell membrane, and also in the cytoplasm, where distribution appeared to reflect that of the sarcoplasmic reticulum. Dual ␣-and ␤ 1 -subunit labeling could not be performed since characterized primary antibodies came from the same host. Peptide block of the primary antibody abolished staining.
Effect of Diet-induced Obesity on Responses to BK Ca Agonists in Cremaster Muscle Arterioles And Middlecerebral Arteries
The BK Ca ␣-subunit-selective activators NS1619 (0.1-300 mol/l; Fig. 4, A and D) and PiMA (0.1-30 mol/l; Fig. 4, B and E) and the ␤ 1 -subunit selective activator tamoxifen (0.01-100 mol/l; Fig. 4, C and F) caused concentration-dependent dilation of pressurized cremaster muscle arterioles (Fig. 4 , A-C) and middle-cerebral arteries (Fig. 4, D-F) . Responses of either vessel from both control and obese rats to NS1619 or PiMA were not significantly different (Fig. 4, A, B, D, and E) . However, tamoxifen was a less potent vasodilator in cremaster muscle arterioles from obese animals (pEC 50 ; control, 5.8 Ϯ 0.2 vs. obese, 5.0 Ϯ 0.1; P Ͻ 0.05, unpaired t-test; n ϭ 6 -10 of each; Fig. 4C ). In contrast, in middle-cerebral arteries, the vasodilatory potency of tamoxifen was increased in obese rats, compared with control (pEC 50 ; control, 5.1 Ϯ 0.2 vs. obese, 6.0 Ϯ 0.2; P Ͻ 0.05, unpaired t-test; n ϭ 9 of each; Fig. 4F ). In control animals, tamoxifen was a less potent dilator in middle-cerebral arteries compared with cremaster muscle arterioles (P Ͻ 0.05, unpaired t-test; n ϭ 6 -9 of each), whereas the opposite was true in the respective vessels from obese animals. IBTX significantly inhibited, but did not abolish, dilation to NS1619 and PiMA in both cremaster muscle arterioles and middle-cerebral arteries from both control and obese rats (Fig.   Fig. 2 . Protein expression of BKCa ␣-subunit (A, D, F, and I) and ␤1-subunit (B, E, G, and J) relative to actin, and the ratio of ␤1-to ␣-subunits (C and H), in cremaster muscle arterioles (A-E) and middle-cerebral arteries (F-J) from control (n ϭ 4) and obese (n ϭ 3) rats. Columns represent means Ϯ SE. *Significant difference compared with control (P Ͻ 0.05, unpaired t-test).
4, A, B, D, and E).
Dilation to tamoxifen was abolished by IBTX in both vessels from control and obese rats (Fig. 4, C  and F) .
Effect of Diet-induced Obesity on Myogenic Tone in Cremaster Muscle Arterioles and Middle-cerebral Arteries
At low pressure (30 mmHg) myogenic tone was increased in cremaster muscle arterioles from obese compared with control rats (Fig. 5C ). At 30 mmHg the diameter of obese arterioles was 68.3 Ϯ 5.7% (of passive diameter, 124.5 Ϯ 4.5 m) compared with 85.9 Ϯ 3.9% (passive 106.1 Ϯ 2.3 m) in control (P Ͻ 0.05). This increase in tone was not evident at higher pressures (50 -120 mmHg). The passive (maximum) diameter of cremaster muscle arterioles from both control and obese rats was similar at all pressures except 30 mmHg, where passive diameter was greater in arterioles from the obese rats (above and Fig. 5D ). IBTX significantly constricted cremaster muscle arterioles from control rats across the entire pressure range (30 -120 mmHg), whereas in arterioles from obese rats IBTX had no significant effect on diameter, at any pressure (Fig. 5A) .
and middle-cerebral vessels (B, C, E, F, I, and L, insets). Labeling was blocked by preincubation of the primary antibody with immunizing peptide (B, C, H, and K, insets).
Myogenic tone of middle-cerebral arteries from both control and obese rats was similar across the pressure range tested (30 -120 mmHg; Fig. 5B ). IBTX constricted middle-cerebral arteries from control rats across the entire pressure range, and this response was not altered in arteries from obese rats (Fig.  5B) . The passive (maximum) diameter of middle-cerebral arteries from both control and obese rats was similar across the pressure range (Fig. 5E) .
Effect of Diet-induced Obesity on the Ultrastructural Characteristics of Cremaster Muscle Arterioles
Increased active tone and passive diameter in cremaster muscle arterioles from obese rats, at low pressures, suggested some remodeling of the arteriolar wall. This was investigated further in perfusion fixed arterioles. In these vessels lumen diameter was not significantly different between arterioles from control and obese rats ( Fig. 6 ; Table 2 ). The number of smooth muscle cell layers, medial thickness, and media-tolumen ratio were significantly larger in cremaster muscle arterioles from obese rats ( Fig. 6 ; Table 2 ). For detail, see Supplemental Table S1 .
DISCUSSION
Consistent with obesity in humans, rats fed a cafeteria-style HFD had significant weight gain and increased fat mass. In addition systolic BP, nonfasting blood glucose, plasma insulin, and leptin were significantly elevated. Hence the changes in BK Ca function observed in this study may better reflect vascular changes in humans compared with genetic models. There are multiple factors that may contribute to obesity-induced vascular dysfunction. Increased body weight and fat mass has been shown to correlate to hyperleptinemia in both humans and animal models of obesity (29, 50, 67) . Increased sympathetic nervous system activity and thus BP is characteristic of obesity-associated hypertension in human and animal models, the etiology of which appears to be multifactorial involving insulin, leptin, and other hormonal factors (42, 50).
Inhibition of BK Ca contributes to increased vascular resistance and BP in some models of obesity, hypertension, and diabetes (15, 23) . The mechanisms underlying BK Ca inhibition are not clear, since disparate results are found in different Comparison of responses to NS1619 (A, n ϭ 14 -16 of each; D, n ϭ 6 -10), pimaric acid (PiMA; B, n ϭ 5-7; E, n ϭ 2 to 3), and tamoxifen (C; n ϭ 6 -10; F, n ϭ 5-10) in the absence and presence of iberiotoxin (IBTX; A; NS1619 with IBTX n ϭ 3 of each; B-F as above) is shown. * And †, significant inhibition of dilation by IBTX in vessels from control and obese rats, respectively; #dilation to tamoxifen was significantly different between vessels from control and obese rats (2-way ANOVA with Bonferroni posttest). models, decreased (3, 15, 47) , increased (4), or no change (6) in ␤ 1 -subunit expression. In the same manner, BK Ca function has also been shown to be decreased (4, 23) or increased (45). In the present study we aimed at a more expansive view by examining the effect of a dietary, rather than genetic, model of obesity on BK Ca expression and function in small resistance vessels from different vascular beds. BK Ca ␤ 1 -subunit protein expression and BK Ca function was reduced in cremaster muscle arterioles, but not middle-cerebral arteries, from obese rats. Indeed, ␤ 1 -subunit protein expression and function (the latter assessed by tamoxifen sensitivity) was increased in middlecerebral arteries from obese rats. Expression or function of the ␣-subunit was not altered in either vessel from obese rats. Consistent with previous studies (24) , immunohistochemistry showed ␣-and ␤ 1 -subunits were present exclusively in the smooth muscle of both vessels from both control and obese rats. It is possible that the antibodies used stained mitochondrial BK Ca , which have been identified in the heart and brain (7).
The changes in BK Ca ␤ 1 -subunit protein expression in vessels from obese rats were not reflected at the mRNA level, suggesting that consequent changes in ␤ 1 expression and function arise at the post-transcriptional level. Neither BK Ca ␤ 1 -subunit mRNA expression nor the ratio of ␤ 1 -to ␣-subunit mRNA was altered in either vessel from obese rats. These observations suggest that the differences in the quantity of ␤ 1 -subunit protein in both vessels in obese animals are more likely due to changes in ␤ 1 protein metabolism rather than a change in overall ␤ 1 protein translation. The observations on mRNA levels are in contrast with those in the streptozotocininduced type 1 diabetic rat, where both BK Ca ␤ 1 -subunit mRNA and protein expression (the latter measured by immunohistochemistry rather than Western blotting) were significantly reduced in retinal arterioles (47). Streptozotocin treatment appears to have a more severe impact on BK Ca ␤ 1 -subunit expression and function.
The ability of BK Ca to modulate myogenic tone in cremaster muscle arterioles from obese rats was abolished, suggesting the ␤ 1 -subunit is crucial to activation of BK Ca by pressure-induced constriction. However, these alterations in BK Ca function had little effect on overall myogenic tone, despite a small increase in tone at 30 mmHg, which was most likely due to vessel wall remodeling and reduced distensibility, rather than altered BK Ca function, since passive (maximum) diameter at this pressure was also increased in obesity. In middle-cerebral arteries BK Ca ␤ 1 -subunit protein expression was increased in obesity, although there was no apparent increase in the role of BK Ca in modulating myogenic tone or any change in overall tone. Consistent with previous studies in the cerebral circulation at physiological pressures, the myogenic response curve of middle-cerebral arteries was relatively flat across the pressure range tested (40, 54, 70). These observations suggest that the effects of diet-induced obesity on BK Ca expression and function are heterogeneous between vessels from different beds. Furthermore, the mechanisms controlling overall myogenic tone can be altered and compensate for a loss or increase in BK Ca expression and function. The mechanisms by which pressure-induced myogenic tone is produced and maintained are complex and not fully understood (30). Other mechanisms that may be altered in obesity to regulate myogenic tone include increased L-type Ca 2ϩ channel activity (4) and altered activity of other K ϩ channels such as those of the voltageactivated type (K V ; 59).
Changes in BK Ca ␤-subunit expression also alter IBTX pharmacology. Dworetzky et al. (17) showed that BK Ca -mediated currents in Xenopus oocytes expressing both ␣-and ␤-subunits were approximately tenfold less sensitive to inhibition by IBTX than BK Ca currents in oocytes expressing the ␣-subunit only. Such observations do not correlate with effects observed in the present study, in that reduced ␤ 1 -subunit expression also reduced the functional effects of IBTX. In this case, it seems more likely that reduced ␤ 1 -expression reduced the ability of the pressure-stimulus to activate the channel. The effects of other BK Ca ␤-subunits on IBTX binding affinity are well established (48), but these subunits are not expressed to a significant extent in vascular smooth muscle. Furthermore, given that reported changes in IBTX affinity for BK Ca resulting from altered expression of any ␤-subunit (including ␤ 1 ) are usually in the picomolar to low-nanomolar range (17, 25, 48) we are confident that the concentration of IBTX used in our study (100 nM) maximally inhibited BK Ca channels regardless of the level of ␤ 1 -subunit expression.
In contrast with the observations of the present study, increased myogenic tone was associated with the loss of the ␤ 1 -subunit in cerebral arteries from streptozotocin-induced type 1 diabetic rats (15) and BK Ca ␤ 1 -subunit knockout mice (5). It is possible that the reduction in ␤ 1 -subunit protein expression observed in cremaster muscle arterioles in our obesity model, despite being sufficient to abolish the effects of IBTX, was not severe enough to affect myogenic tone. It is worth noting that, apart from one study in streptozotocininduced diabetes (15) , few investigations in this area have actually measured BK Ca ␤ 1 -protein expression. This may be due to the difficulty of working with small vessels, where it is necessary to pool tissue from several animals. It should also be mentioned that in both diabetic Zucker (6) and streptozotocintreated (15, 47) rats the extent of hyperglycemia and hyperinsulinemia was much greater than in our dietary obese model, and these animals did not experience weight gain or hypertension compared with control animals. Furthermore, there is also evidence of increased frequency or amplitude of Ca 2ϩ sparks; or altered coupling between Ca 2ϩ sparks and BK Ca in vascular smooth muscle cells from diabetic models (15, 47, 49) . Of interest, in a recent study Ca 2ϩ sparks could not be detected in smooth muscle from rat cremaster muscle arterioles (69) . Nevertheless, the reduction in the ␤ 1 -subunit in the present study was functionally significant, as shown by the inability of IBTX to constrict these vessels and the reduced response of intact arterioles to the BK Ca ␤ 1 -selective activator tamoxifen. Tamoxifen and the related compound 17␤-estradiol are estab- (Table 2 and  Supplemental Table S1 ). Insets show higher magnification of the respective vessel walls. Adv, adventitia; EC, endothelium; iel, internal elastic lamina. For A and B, scale bar ϭ 50 m; for insets, scale bar ϭ 5 m.
lished, selective activators of the BK Ca ␤ 1 -subunit (11, 12, 13) , and in the present study tamoxifen-induced dilation was abolished by IBTX in both vessels, suggesting this vasodilation was mediated exclusively by BK Ca . In middle-cerebral arteries dilation to tamoxifen was relatively small and, combined with the relatively large constriction induced by IBTX, suggests a high level of BK Ca activity, consistent with previous studies demonstrating the importance of BK Ca in the cerebral circulation (52).
The present study found BK Ca ␣-subunit mRNA and protein expression and function was not altered in either cremaster muscle arterioles or middle-cerebral arteries from obese rats. The different appearance of the smeared BK Ca ␣-band (100 -110 kDa) in cremaster muscle arterioles compared with middle-cerebral arteries is most likely due to ␣-subunit splice variants and/or phosphorylation sites (68) . There was no evidence of reduced ␣-subunit expression or functional inhibition in either vessel from diet-induced obese rats, as established by selective ␣-subunit activators NS1619 (28) and PiMA (34) in the present study. IBTX abolished dilation induced by either NS1619 or PiMA over most of the active concentration range of these agents, in vessels from both control and obese rats, suggesting these effects were mediated solely by BK Ca . It is well known that high concentrations of NS1619 also inhibit K V and L-type Ca 2ϩ channels (18, 32) , reflected in the present study by the inability of IBTX to inhibit the vasodilation caused by supramaximal concentrations of NS1619 (Ͼ30 M).
Increased myogenic tone and passive diameter, at low pressures in cremaster muscle arterioles from obese rats, indicated remodeling. Electron microscopy showed that both medial thickness and media-to-lumen ratio were significantly increased in cremaster muscle arterioles from obese rats, which differs from the morphological changes described in studies using the obese Zucker rat (22, 63) . In contrast with the diet-induced obesity model, reduced lumen diameter and atrophy of the vascular wall was observed in gracilis arteries from OZR, although in middle-cerebral arteries no remodeling was observed (63) . In a separate study, cerebral arteries from OZR had increased myogenic tone and inward remodeling (53) . Inward, eutrophic remodeling has been observed in cremaster muscle arterioles in one-kidney one-clip hypertension (55) . In cerebral arteries from HFD-fed rats reduced lumen diameter, increased wall thickness and wall-to-lumen ratio were observed (10) . There was no functional evidence of remodeling in middle-cerebral arteries from our diet-induced obese rats. Collectively, these data suggest that there is considerable heterogeneity in remodeling that is vascular bed and model specific.
The obesity-related factor(s) that caused the changes in BK Ca ␤ 1 -expression and BK Ca function are difficult to identify. Of the factors measured (leptin, insulin, and blood glucose), insulin has been shown to increase BK Ca expression and function in the plasma membrane of mouse podocytes, whereas high concentrations of glucose had the opposite effect (38). In contrast with the current findings, BK Ca function was inhibited in cerebral arteries from insulin-resistant rats (19) . There is evidence that leptin activates BK Ca in rat hippocampal neurons (61) . In HEK-293 cells leptin increased BK Ca activity both in cells expressing the ␣-subunit alone and in the presence of the ␤ 1 -subunit (61) . Periadventitial adipose tissue has been shown to secrete an unknown factor called ADRF that is believed to act via K V , K ATP , and BK Ca (26) . Caveolins play an important role in cell signaling and distribution of receptors, channels, and effectors (56) . Interaction between caveolin-1 and BK Ca affects the function and surface expression of BK Ca channels (1, 9) . In coronary arterioles from diet-induced obese rats, reduced protein expression of caveolin-1 was associated with enhanced BK Ca activity (21) . Substantial further investigation is required to determine which of these factors, or factors acting in combination, are responsible for altering BK Ca ␤ 1 -subunit expression in obesity.
In summary, the effect of diet-induced obesity on BK Ca differs in skeletal muscle and central microvasculature. Both functional and protein expression data show that the ␤ 1 -subunit is impaired in skeletal muscle arterioles but enhanced in cerebral arteries, although neither alteration affected myogenic tone over the physiological pressure range in these vessels. Increased myogenic tone at low pressures observed in skeletal muscle arterioles is likely due to vessel remodeling. Data suggest that elevated BP observed in our diet-induced obese rats is not due to increased myogenic tone of the vessels studied. Nevertheless, it is clear that diet-induced obesity altered the fundamental mechanisms by which myogenic tone, vital to control of blood flow, is regulated in these two vascular beds, specifically by altering the role of BK Ca . Furthermore, the mechanisms controlling overall myogenic tone can be altered and compensate for a loss or increase in BK Ca expression and function. Future studies examining the effect of diet-induced obesity on BK Ca -dependent pathways may determine the mechanisms involved. 
